Pharmacological inhibition of monoacylglycerol lipase enhances IGM plasma levels and limits atherogenesis in a CB2-dependent manner
Guillamat-prats, R., Rami, M., Ring, L., Rinne, P., Lenglet, S., Lauer, E., Thomas, A., Cravatt, B., Weber, C., Faussner, A., Steffens, S.Volume:
275
Language:
english
Journal:
Atherosclerosis
DOI:
10.1016/j.atherosclerosis.2018.06.116
Date:
August, 2018
File:
PDF, 50 KB
english, 2018